October 14, 2011
In its consolidated settlement of accounts for December 2010-August 2011, Nichi-Iko Pharmaceutical posted sales of ¥56,524 million, +20.5% compared to the corresponding period of the previous year, due to the transfer of long-listed products from sanofi-aventis and the government’s generic...read more